The high expression of ADAMTSL2 could promote the activation of ECM receptor interaction, MAPK signaling pathway, Wnt signaling pathway, and pathways in cancer, while the low expression of ADAMTSL2 could inhibit the biosynthesis of unsaturated fatty acid (Figure S4A). The gene discussed is ADAMTSL2; the disease is cancer.